Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04530812 · ClinicalTrials.gov registry record · NA
Fermented Milk Supplementation on Symptoms of Disease and Treatment in Patients With Multiple Myeloma
A NA study, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT04530812 is a NA study that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 13 participants.
The verdict
NCT04530812, a NA study, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
This trial investigates the effect of fermented milk supplementation on symptoms of disease and treatment in patients with multiple myeloma. Patients with multiple myeloma may experience symptoms related to the disease and/or treatment that affect quality of life. Supplementing usual diet with a probiotic fermented milk product called kefir may contribute to reducing disease and treatment-related side effects through changing the intestinal bacteria community structure and related metabolism.
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
- OTHER Best Practice
- DIETARY_SUPPLEMENT Kefir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2020-08-24 |
| Est. Completion | 2021-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04530812
The ClinicalTrials.gov registry entry for NCT04530812 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Quality-of-Life Assessment is the first listed.
NCT04530812 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04530812 about?
NCT04530812 is a clinical study titled "Fermented Milk Supplementation on Symptoms of Disease and Treatment in Patients With Multiple Myeloma". This trial investigates the effect of fermented milk supplementation on symptoms of disease and treatment in patients with multiple myeloma. Patients with multiple myeloma may experience symptoms related to the disease and/or treatment that affect quality of life. Supplementing usual diet with a pro...
What is the current status of trial NCT04530812?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2020-08-24. Estimated completion is 2021-08-30.
What interventions are being tested in trial NCT04530812?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Best Practice (OTHER), Kefir (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04530812?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.